Japan Tobacco Inc.

Japan Tobacco Inc.

JAPAF
Japan Tobacco Inc.US flagOther OTC
35.78
USD
-4.50
- -
63.52BMarket Cap
Japan Tobacco Inc.
JAPAF
(Other OTC)

Recent

price

35.78

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
1,075.5
1,068.02
1,117.28
1,320.4
1,111.22
1,254.91
1,196.78
1,194.67
1,237.07
1,224.48
1,179.49
1,310.2
1,497.58
1,600.48
1,721.57
1,953.18
1,700.04
Revenue per Share
127.07
168.5
181.07
235.48
199.67
270.54
235.47
219.1
215.31
195.97
174.88
190.76
249.45
271.69
100.95
287.36
281.89
Basic EPS, GAAP
137.33
229.8
175.88
135.34
236.19
189.02
148.28
155.82
168.92
229.09
231.78
279.52
216.59
253.36
270.14
198.08
274.43
Free Cash Flow per Basic Share
29.02
40
60.2
83.94
99.93
104.52
128.02
135.99
144.96
152.45
153.95
141.98
149.98
206.93
196.92
201
193.94
Dividend per Share
592.26
718.68
827.41
1,024.79
1,101.71
1,279.29
1,377.57
1,471.95
1,541
1,604.31
1,625.43
1,670.32
1,797.39
1,854.68
1,766.74
1,866.37
1,936.22
Book Value per Share
49.62
156.56
119.7
344.73
395.15
423.2
280.36
263.34
105.48
169.17
184.03
291.91
520.78
616.98
252.32
448.71
792.29
Tangible Book Value per Share
1,915
1,904
1,898
1,818
1,818
1,795
1,791
1,791
1,791
1,777
1,774
1,774
1,775
1,775
1,776
1,775
1,775
Basic Weighted Avg Shares
2,059,365
2,033,825
2,120,196
2,399,841
2,019,745
2,252,884
2,143,287
2,139,653
2,215,962
2,175,626
2,092,561
2,324,838
2,657,832
2,841,077
3,056,709
3,467,675
3,018,157
Sales/Revenue/Turnover
26.25
22.48
24.97
26.94
22.02
24.81
27.38
25.93
25.32
22.86
22.22
21.29
24.29
23.37
9.86
24.62
22.62
Operating Margin (%)
117,954
118,845
116,462
132,921
122,171
139,057
140,794
145,407
158,671
183,852
179,654
187,057
199,651
177,409
179,837
195,899
181,445
Depreciation Expense
243,315
320,883
343,596
427,987
362,919
485,691
421,695
392,409
385,676
348,190
310,254
338,490
442,716
482,289
179,240
510,175
500,451
Net Income, GAAP
35.43
25.56
31
31.58
26.43
28.74
26.37
26.33
27.1
22.27
25.72
27.99
25.15
21.93
22.47
32.27
22.14
Effective Tax Rate (%)
11.82
15.78
16.21
17.83
17.97
21.56
19.68
18.34
17.4
16
14.83
14.56
16.66
16.98
5.86
14.71
16.58
Profit Margin (%)
181,373
173,576
100,178
233,879
336,776
532,297
249,416
229,144
379,221
423,916
680,126
820,963
1,160,927
1,332,285
1,428,965
1,783,845
1,727,151
Working Capital
478,154
279,750
270,399
166,165
101,001
215,938
339,036
346,955
727,314
690,367
817,412
775,721
821,003
908,926
1,548,120
1,599,061
1,075,931
LT Debt
1,601,311
1,714,626
1,892,430
2,596,091
2,622,503
2,521,525
2,528,041
2,842,027
2,700,445
2,743,612
2,599,494
2,886,081
3,616,761
3,912,492
3,848,727
4,115,389
4,525,292
Total Equity
12.97
14.76
16.09
16.61
11.05
13.83
14.39
12.09
11.08
10.26
9.35
9.58
11.44
10.69
4.37
10.12
9.83
Return on Invested Capital (%)
11.94
17.19
18.17
20.28
15.85
20.04
15.21
12.47
11.35
9.6
9.05
9.38
12.45
12.67
6.32
12.83
12.66
Return on Capital (%)
19.12
25.64
23.38
24.94
18.78
22.59
17.7
15.38
14.29
12.41
10.82
11.58
14.39
14.88
5.58
15.82
14.91
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Dec'23
Mar'24
Jun'24
ST Debt
233,333
80,321
76,545
LT Borrowings
908,926
939,268
1,075,931
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,775
1,775
1,776
Market Capitalization
6,547,299
6,995,610
8,073,647

Working Capital

FRC

in mil. unless spec.
Dec'23
Mar'24
Jun'24
Total Current Assets
3,259,561
2,984,811
3,461,403
Cash, Cash Equivalents & STI
1,098,839
817,407
1,112,324
Accounts Receivable, Net
535,302
571,262
657,917
Inventories
832,611
875,469
941,571
Total Current Liabilities
1,927,276
1,629,808
1,734,252
Payables & Accruals
- -
- -
- -
ST Debt
233,333
80,321
76,545
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
5.39%
9.96%
6.93%
Free Cash Flow
2.24%
-0.98%
-26.68%
Net Income, GAAP
12.82%
34.12%
184.63%
Sales/Revenue/Turnover
4.62%
10.67%
13.44%
Total Cash Common Dividend
7.33%
6.63%
2.06%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
740,333
829,559
- -
- -
3,056,709
2025
- -
- -
- -
- -
3,467,675
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
88.58
- -
- -
- -
100.95
2025
- -
- -
- -
- -
287.36
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
97.28
- -
- -
- -
196.92
2025
- -
- -
- -
- -
201
2026
- -
- -
- -
- -
- -
Business
Japan Tobacco Inc. (Ticker: JAPAF) is a leading international tobacco company primarily engaged in the manufacture, marketing, and sale of tobacco products. Its core product portfolio includes cigarettes, cigars, smokeless tobacco products, and tobacco-related electronic devices; these are marketed under several well-known brands including Winston, Mevius, Camel (outside the US), and LD. The company also has diversified operations in pharmaceuticals and processed food products. Japan Tobacco operates globally with a strong presence in Japan, Europe, Asia, and the Americas. Founded in 1985 and headquartered in Tokyo, Japan, it is a major player in both domestic and international tobacco markets. In recent years, Japan Tobacco has focused on expanding its reduced-risk product offerings, emphasizing electronic nicotine delivery systems (ENDS) and heat-not-burn tobacco products to align with shifting consumer preferences and regulatory landscapes. Notably, in the past 1-2 years, the company has entered strategic partnerships to advance its R&D in new tobacco technologies and has launched new heat-not-burn products targeting key markets in Asia and Europe. Additionally, Japan Tobacco has undertaken acquisitions to strengthen its pharmaceutical business segment and has made operational shifts to streamline production and distribution. These efforts reflect a strategic shift towards diversification beyond traditional tobacco products while maintaining its core tobacco portfolio. Japan Tobacco operates through segments including Domestic Tobacco business, International Tobacco business, Pharmaceutical business, and Processed Food business, targeting diverse customer bases ranging from adult smokers to pharmaceutical consumers. It has subsidiaries and affiliates spread across various regions, supporting its multinational footprint. The company remains publicly traded and continues to adapt in a volatile regulatory and consumer landscape while maintaining its status as a dominant tobacco and diversified consumer products enterprise headquartered in Tokyo.

Company News

APIChat
  • Japan Tobacco: Steady As She Goes

  • Japan Tobacco Inc. (JAPAY) Q1 2026 Earnings Call Transcript

  • Seeking Safety In High Yield Tobacco

  • Japan Tobacco Inc. (OTCMKTS:JAPAF) Sees Significant Decline in Short Interest

  • Japan Tobacco Inc. (JAPAY) Q4 2025 Earnings Call Transcript

  • Japan Tobacco: A 'Buy' On Beat & Raise Quarter, Profitability Outlook

  • Japan Tobacco Inc. (JAPAY) Q3 2025 Earnings Call Transcript

  • Japan Tobacco Inc. (JAPAY) Q2 2025 Earnings Call Transcript

  • High-Yield Tobacco: Relative Quality

  • Japan Tobacco: Staying Positive On New Product And Non-Core Disposal

  • Japan Tobacco Inc. (JAPAY) Q1 2025 Earnings Call Transcript

  • Japan Tobacco: Enjoy The Income While Waiting For Growth

  • Japan Tobacco Inc. (JAPAY) Full Year 2024 Earnings Call Transcript

  • Japan Tobacco: Look Beyond In-Line Results And Consider Its Favorable Prospects (Rating Upgrade)

  • Japan Tobacco Inc. (JAPAY) Q3 2024 Earnings Call Transcript

  • Japan Tobacco: The Vector Group Acquisition Impact

  • Japan Tobacco: It's All About The Yen (Rating Downgrade)

  • Japan Tobacco Inc. (JAPAF) Q4 2023 Earnings Call Transcript

  • Japan Tobacco Inc. (JAPAF) Q3 2023 Earnings Call Transcript

  • Japan Tobacco: Accelerating Growth Justifies A Higher Valuation